Robbyant's embodied AI challenge draws over 1,800 teams to Shanghai
More than 1,800 teams from 13 countries have entered a contest built on Robbyant's open-source LingBot-VLA 2.0 model…
World Laureates Forum opens Oct 30 with 33 award recipients
The three-day meeting at the Lingang Center in Shanghai will gather 33 recipients of major international awards…
STARMUS VIII holds six days of science and music across Tenerife and La Palma
The eighth edition of the STARMUS festival ran from 17 to 22 October 2026 on two Canary Islands, with an Artemis II…
World Young Scientist Summit 2026 opens in Wenzhou with nearly 800 delegates
The summit, hosted by China's science association, Zhejiang province and a young scientists' body, is being held under…
Ractigen publishes peer-reviewed study of its LiCO extrahepatic RNA delivery platform
The paper reports months-long silencing in muscle, heart and fat in animals, local delivery to joint, eye and bladder…
Rakuten Medical reports 44.3-month median response duration in head and neck cancer follow-up
Long-term data from a 19-patient Phase 1b/2 study of ASP-1929 photoimmunotherapy with pembrolizumab were presented at…
Chongqing forum opens with 800 delegates on cars, robots and outbreak modelling
The 2026 World Science and Technology Development Forum brought industry, UN, robotics and epidemiology speakers to…
Minesto joins Sweden-Indonesia partnership to pursue tidal energy in Indonesia
The Gothenburg ocean energy developer will work with Business Sweden on partner search, financing access and project…
Rondo and Rio Tinto start design work on 360 MWh heat battery for Yarwun alumina refinery
Front-end engineering and design has begun on a thermal energy storage project at Rio Tinto's Gladstone refinery…
Gairdner Science Week 2026 brings laureates to Toronto for free public lectures
The Gairdner Foundation's five-day programme, held in Toronto and streamed online, centres on the 2026 Canada Gairdner…
Vivacta Bio receives FDA orphan drug designation for GT801 in AIHA
The Shanghai company, spun out of Grit Bio's in vivo CAR-T platform, said the designation covers its lead candidate for…
FDA Clears Phase 2 Study of T-MAXIMUM's MT027 in Brain Metastases
The company said the allogeneic CAR-T therapy will be tested in patients whose cancer has spread to the brain from lung…